• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » FDA Offers Advice on Standardizing Real-World Data for IND Submissions

FDA Offers Advice on Standardizing Real-World Data for IND Submissions

October 25, 2021

The FDA has acknowledged the challenges sponsors face in standardizing study data taken from real-world data (RWD) sources and issued draft guidance to help sponsors make adjustments.

These hurdles include the variety of RWD sources and their inconsistent formats; the differences in source data obtained regionally and globally using different standards, exchange formats and terminologies to represent the same or similar data elements; the variety of methods and algorithms used to make datasets meant to aggregate data; and the many elements of healthcare data that can impact overall data quality.

Sponsors are required to use the data formats and standards outlined in the agency’s Study Data Guidance and Data Standards Catalog when submitting study data derived from RWD in investigational new drug (IND) applications.

Because of this, the agency advises sponsors to refer to the Study Data Technical Conformance Guide, which outlines how to submit standardized study data that meet agency expectations.

In addition, when conforming RWD to agency-supported data standards, sponsors should consider the data transformations, conversions or mappings that may be needed to produce adequate study datasets. To aid them in this, the guidance provides sponsors with considerations to make when mapping and transforming RWD.

Importantly, sponsors are encouraged to communicate with the FDA early on if they plan to include study data taken from RWD sources in an applicable submission. If so, they should describe the approaches they intend to use to convert the data to supported data standards in the protocol, data management plan and/or final study reports.

The FDA said it intends to release further guidance on the subject and/or update the catalog with standards for study data taken from RWD sources.

Read the full guidance here: https://bit.ly/3C3LXQF.

 

To view more CenterWatch Weekly stories, click here.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing